What the interventionalist should know about renal denervation in hypertensive patients: A position paper by the ESH WG on the interventional treatment of hypertension

Costas Tsioufis, Felix Mahfoud, Giuseppe Mancia, Josep Redon, Bruno Damascelli, Thomas Zeller, Roland E. Schmieder

Research output: Contribution to journalArticle

Abstract

Percutaneous catheter-based transluminal renal denervation (RDN) has emerged as a new approach to achieve sustained blood pressure reduction in patients with drug-resistant hypertension. Experts from ESH and ESC in their recently released position papers and consensus document have summarised the current evidence, unmet needs and practical recommendations for the application of this therapeutic strategy in clinical practice. Experts of the ESH Working Group for the interventional treatment of hypertension prepared this position paper in order to provide interventionalists with guidance through the procedure of RDN. Given that there is no established intraprocedural control of ablation success, interventionalists have to be familiar with the aspects related to the anatomy and imaging of the renal arteries, the distribution of renal sympathetic fibres, the special equipment necessary for RDN and the procedural details in order to maximise the success and minimise potential complications.

Original languageEnglish
Pages (from-to)1027-1035
Number of pages9
JournalEuroIntervention
Volume9
Issue number9
Publication statusPublished - Jan 2014

    Fingerprint

Keywords

  • Ablation devices
  • Renal denervation
  • Resistant hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Tsioufis, C., Mahfoud, F., Mancia, G., Redon, J., Damascelli, B., Zeller, T., & Schmieder, R. E. (2014). What the interventionalist should know about renal denervation in hypertensive patients: A position paper by the ESH WG on the interventional treatment of hypertension. EuroIntervention, 9(9), 1027-1035.